ADVENZYMES Share Price Target 2050

CAGR-based price projection for Advanced Enzyme Technologies Limited (ADVENZYMES) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-3.1% CAGR)
Rs 128
2050 Target
Base Case (-7.8% CAGR)
Rs 39
2050 Target
Bull Case (-11.8% CAGR)
Rs 14
2050 Target

Current Market Snapshot

CMP: Rs 274.25
52W High: Rs 392.10
52W Low: Rs 274.25
1Y CAGR: -15.1%
3Y CAGR: -7.8%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 266 Rs 253 Rs 242
2028 Rs 257 Rs 233 Rs 213
2029 Rs 249 Rs 215 Rs 188
2030 Rs 241 Rs 198 Rs 166
2031 Rs 234 Rs 182 Rs 147
2032 Rs 226 Rs 168 Rs 129
2033 Rs 219 Rs 155 Rs 114
2034 Rs 212 Rs 143 Rs 101
2035 Rs 206 Rs 131 Rs 89
2036 Rs 199 Rs 121 Rs 78
2037 Rs 193 Rs 112 Rs 69
2038 Rs 187 Rs 103 Rs 61
2039 Rs 181 Rs 95 Rs 54
2040 Rs 175 Rs 87 Rs 48
2041 Rs 170 Rs 81 Rs 42
2042 Rs 165 Rs 74 Rs 37
2043 Rs 159 Rs 68 Rs 33
2044 Rs 154 Rs 63 Rs 29
2045 Rs 150 Rs 58 Rs 25
2046 Rs 145 Rs 54 Rs 22
2047 Rs 140 Rs 49 Rs 20
2048 Rs 136 Rs 45 Rs 17
2049 Rs 132 Rs 42 Rs 15
2050 Rs 128 Rs 39 Rs 14

Other ADVENZYMES Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the ADVENZYMES share price target for 2050?

Based on historical growth analysis, the ADVENZYMES share price target for 2050 ranges from Rs 128 (conservative) to Rs 39 (base case) to Rs 14 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of ADVENZYMES?

The current market price of ADVENZYMES (Advanced Enzyme Technologies Limited) is Rs 274.25. The 52-week high is Rs 392.10 and 52-week low is Rs 274.25.

Is ADVENZYMES a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for ADVENZYMES price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -3.1% CAGR), Base (-7.8% CAGR), and Bull (optimistic at -11.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.